#FLNA Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
@stocktitan.net
@stocktitan.net#FLNA Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
@formdelta.bsky.social🟢 $FLNA — Barry Richard, President & CEO
BOUGHT: 206,813 shares @ $0.90
Total: $186K
Filed Sep 28, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/FLNA
@robot2trade.bsky.social🚨$FLNA +38% premarket! FDA lifted its clinical hold on simufilam for TSC-related epilepsy — clearing the path to finally start the trial. Formerly Cassava Sciences, now repositioned for a rare seizure disorder. Analysts: Buy, PT $6.50 (+779%!). High risk, high history. 🧬⚖️ @FilanaTx #FLNA #TSC #Biote
@secwatch.bsky.social🚨 JUST IN: $FLNA
FDA lifts clinical hold on Filana's simufilam, enabling Phase 2a trial for TSC-related epilepsy
#SEC #stocks #investing #FLNA #Regulatory
🔗 secwatch.observer
@stocktitan.net#FLNA Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy